Published Date: November 24, 2022
U.S. Ambulatory Surgical Centers Market size is anticipated to reach USD 54 billion by 2032, according to a new research report by Global Market Insights Inc
Lower vulnerability to healthcare-associated infections (HAIs) in comparison to hospitals is a key factor enhancing the development of ASCs in the United States. A patient is ten times more likely to contract an infection at a hospital, than at an ambulatory surgical center. Furthermore, these healthcare settings have specialized facilities for surgical procedures that are needed to comply with strict safety norms. The Centers for Disease Control and Prevention (CDC) mandates ASCs to set up early detection, investigation, and control for infectious and communicable diseases, thus reducing the risk of SSI (surgical site infections).
U.S. ambulatory surgical centers market from the physician & corporation ownership segment is projected to record over 3% CAGR from 2023 to 2032. These facilities employ several experienced physicians addressing various ailments. Such settings allow effective patient-oriented care and treatment, as the financial tasks are undertaken by the corporation. Collaboration is also prevalent in facilities such as corporation and physician-owned ASCs, enabling the delivery of all-around patient care and bolstering market size.
U.S. ambulatory surgical centers market from the ophthalmology surgery segment is expected to depict over 4.5% CAGR between 2023 to 2032. Increased usage of smartphones and laptops has led to a surge in various eye disorders, such as dry eye diseases. The screens of these devices emit blue light which can harm the cornea and can lead to macular degeneration. With rising digitization, the use of such devices has risen exponentially, leading to a surge in the prevalence of eye disorders and in turn, stimulating the demand for ophthalmological surgeries in ambulatory surgical centers across the U.S.
Browse key industry insights spread across 103 pages with 54 market data tables & 17 figures & charts from the report, “U.S. Ambulatory Surgical Centers Market Size By Ownership (Physician Only, Hospital Only, Corporation Only, Physician & Hospital, Physician & Corporation, Hospital & Corporation), By Surgery Type (Dental, Otolaryngology, Endoscopy, Obstetrics/Gynecology, Ophthalmology, Orthopedic, Cardiovascular, Neurology, Plastic Surgery, Podiatry), By Specialty Type (Single Specialty, Multi-specialty), By Service (Diagnosis, Treatment), Industry Analysis Report, Growth Potential, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2023 – 2032” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/us-ambulatory-surgical-centers-market
U.S. ambulatory surgical centers market from the single specialty segment is anticipated to record over 4% CAGR from 2023 to 2032. This can be attributed to the increasing establishment of single-specialty ASCs. These facilities are cost-effective and pose minimal risk of physical attrition. The increased demand for advanced healthcare facilities across remote areas will also boost the development of single-specialty ambulatory surgical centers in the United States.
Diagnosis service segment was worth more than USD 9.5 billion in 2022. The general population has grown increasingly aware of various diseases, which has prompted frequent health checkups for disease diagnosis. ASCs offer advanced technologies for early disease diagnosis in addition to high-quality care at affordable costs. With the growing requirement for high-quality healthcare services, the use of ASCs for the early detection of different diseases will thus improve market dynamics.
Some of the major companies operating in the U.S. ambulatory surgical centers market include AMSURG (Kohlberg Kravis Roberts & Co. L.P.), ASD Management, Elite Surgical Center (Nobilis Health Corp.), HCA Healthcare, Medical Facilities Corporation, Physicians Endoscopy, Pinnacle III, Proliance Surgeons, and Regent Surgical Health. Many of these players are focusing on expanding their businesses by collaborating with other industry players.
Sumant Ugalmugle, Rupali Swain